Mounjaro Dosage. Mounjaro is a subcutaneously injected medication that offers effective glycemic control for patients with diabetes. In this article, we will explore the recommended dosage guidelines for Mounjaro and provide essential information to help patients optimize their treatment regimen.
To initiate treatment with Mounjaro, it is recommended to start with a dosage of 2.5 mg injected subcutaneously once weekly. This initial dosage is not intended for glycemic control but rather serves as a starting point for therapy.
After four weeks of treatment initiation, the dosage of Mounjaro should be increased to 5 mg injected subcutaneously once weekly. This adjustment aims to enhance glycemic control and ensure the medication’s effectiveness.
In cases where additional glycemic control is required, the dosage of Mounjaro can be further increased. It is advised to increase the dosage in 2.5 mg increments after at least four weeks on the current dose. This gradual adjustment allows patients to monitor their response to the medication and make appropriate modifications.
The maximum recommended dosage of Mounjaro is 15 mg injected subcutaneously once weekly. This dosage should not be exceeded, as higher doses may not provide additional benefits and could increase the risk of side effects.
In the event of a missed dose, it is important for patients to follow specific instructions to ensure consistent treatment.
- If a dose is missed, patients should administer Mounjaro as soon as possible within four days (96 hours) after the missed dose.
- If more than four days have passed since the missed dose, the patient should skip it and administer the next dose on the regularly scheduled day.
- Regardless of whether the missed dose is administered or skipped, patients should resume their regular once-weekly dosing schedule afterward.
Changing the Day of Weekly Administration
In certain situations, patients may need to change the day of their weekly Mounjaro administration. However, it is essential to maintain a minimum time interval between two consecutive doses. Patients can change the day of administration if necessary, as long as there is at least a three-day interval (72 hours) between the two doses. This flexibility allows individuals to adapt their treatment schedule to accommodate personal preferences or unforeseen circumstances.